MIRNAs affect the expression of innate and adaptive immunity proteins in celiac disease

American Journal of Gastroenterology

Volumn 109, Issue 10, 2014, Pages 1662-

  Magni, Serena ^a   Comani, Gaia Buoli ^a   Elli, Luca ^b   Vanessi, Samanta ^a   Ballarini, Elisa ^a   Nicolini, Gabriella ^a   Rusconi, Michela ^a   Castoldi, Mirco ^c,d   Meneveri, Raffaella ^a   Muckenthaler, Martina U ^c   Bardella, Maria Teresa ^b   Barisani, Donatella ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CXCL2 CHEMOKINE; GLIADIN; GLUTEN; INTERLEUKIN 18; MICRORNA; MICRORNA 192; MICRORNA 194; MICRORNA 197; MICRORNA 31; MICRORNA 338; MICRORNA 483; MICRORNA 517; MICRORNA 638; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; MIRN192 MICRORNA, HUMAN; MIRN197 MICRORNA, HUMAN; MIRN31 MICRORNA, HUMAN; MIRN338 MICRORNA, HUMAN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DUODENUM BIOPSY; DUODENUM MUCOSA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; LASER MICRODISSECTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CASE CONTROL STUDY; COHORT ANALYSIS; DUODENUM; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ADULT; CASE-CONTROL STUDIES; CELIAC DISEASE; COHORT STUDIES; DUODENUM; FEMALE; HUMANS; IMMUNITY, INNATE; INTESTINAL MUCOSA; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED;

EID: 84924928436     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.203     Document Type: Article

References (59)

1. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009; 137:1912-33.
2. Zanzi D, Stefanile R, Santagata S et al. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in celiac disease. Am J Gastroenterol 2011; 106:1308-17.
3. Hmida N.B., Ben Ahmed M, Moussa A et al. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease? Am J Gastroenterol 2012; 107:604-11.
4. Tiittanen M, Westerholm-Ormio M, Verkasalo M et al. Infiltration of fork-head box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes. Clin Exp Immunol 2008; 152:498-507.
5. Van Leeuwen M A, Du Pr M F, Van Wanrooij R L et al. Changesinnatural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+) Treg in the circulation of celiac disease patients. PLoS One 2013; 8: e68432.
6. Maiuri L, Ciacci C, Ricciardelli I et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003; 362:30-7.
7. Kawai T, Akira S. Terole of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-84.
8. Areschoug T, Gordon S. Pattern recognition receptors and their role in innate immunity: focus on microbial protein ligands. Contrib Microbiol 2008; 15:45-60.
9. Gribar SC, Anand RJ, Sodhi CP The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol 2008; 83:493-8.
10. Walsh D, McCarthy J, O'Driscoll C et al. Pattern recognition receptors-molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev 2013; 24:91-104.
11. Ohtsuka Y, Sanderson IR Dextran sulfate sodium-induced inflammation is enhanced by intestinal epithelial cell chemokine expression in mice. Pediatr Res 2003; 53:143-7.
12. Wu F, Zikusoka M, Trindade A. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2. Gastroenterology 2008; 135:1624-35.
13. Benko S, Philpott DJ, Girardin SE The microbial and danger signals that activate Nod-like receptors. Cytokine 2008; 43:368-73.
14. Carneiro LA, Magalhaes JG, Tattoli I et al. Nod-like proteins in inflammation and disease. J Pathol 2008; 204:136-48.
15. Kalliomäki M., Satokari R, Lähteenoja H et al. Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J Pediatr Gastroenterol Nutr 2012; 54:727-32.
16. Szebeni B, Veres G, Dezsöfi A et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol 2008; 151:34-41.
17. Westerholm-Ormio M., Vaarala O, Tiittanen M et al. Infiltration of Foxp3-and Toll-like receptor-4-positive cells in the intestines of children with food allergy. J Pediatr Gastroenterol Nutr 2010; 50:367-76.
18. Junker Y, Zeissig S, Kim SJ et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of Toll-like receptor 4. J Exp Med 2012; 209:2395-408.
19. Tili E, Michaille JJ, Croce CM Micro RNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev 2013; 253:167-84.
20. Capuano M, Iaffaldano L, Tinto N et al. MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients. PLoS One 2012; 6:e29094.
21. Vaira V, Roncoroni L, Barisani D et al. MicroRNA profiles in celiac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts. Clin Sci Lond 2014; 126:417-23.
22. Oberhuber G. Histopathology of celiac disease. Biomed Pharmacoter 2000; 14:368-72.
23. Wu F, Zikusoka M, Trindade A et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135:1624-35.
24. Rouas R, Fayyad-Kazan H, El Zein N et al. Human natural Treg micro RNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 2009; 39:1608-18.
25. Chen L, Li C, Peng Z et al. miR-197 expression in peripheral blood mononuclear cells from hepatitis B virus-infected patients. Gut Liver 2013; 7: 335-42.
26. Lettesj H, Hansson T, Bergqvist A et al. Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease. Clin Exp Immunol 2005; 139:138-43.
27. McKenna LB, Schug J, Friedman JR et al. MicroRNAs control intestinal epithelial differentiation architecture and barrier function. Gastroenterology 2010; 139:1654-64.
28. Georges SA, Biery MC, Kim S et al. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res 2008; 68:10105-12.
29. Feng S, Cong S, Zhang X et al. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 2011; 39:6669-78.
30. Xie Q, He X, Chang Y et al. MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells. Biochem Biophys Res Commun 2011; 410:440-5.
31. Schee K, Lorenz S, Worren MM et al. Deep sequencing the micro RNA trascriptome in colorectal cancer. PLoS One 2013; 8:e66165.
32. Chiang Y, Song Y, Wang Z et al. MicroRNA-192,-194 and-215 are frequently down-regulated in colorectal cancer. Exp Ther Med 2012; 3: 560-6.
33. Wang G, Tam LS, Li EK et al. Serum and urinary free micro RNA level in patients with systemic lupus erythematosus. Lupus 2011; 20:493-500.
34. Wu TH, Pan CY, Lin MC et al. In vivo screening of zebrafish microRNA responses to bacterial infection and their possible roles in regulating immune response genes after lipopolysaccharide stimulation. Fish Physiol Biochem 2012; 38:1299-310.
35. Chuang AY, Chuang JC, Zhai Z et al. NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells. Inflamm Bowel Dis 2014; 20:126-35.
36. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Gen 2001; 10:445-56.
37. Wu F, Dassopoulos T, Cope L et al. Genome-wide expression differences between Crohn's and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007; 13:807-21.
38. Strober W, Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol 2011; 13:484-95.
39. Watanabe T, Kitani A, Murray PJ et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5:800-8.
40. Fritz JH, Girardin SE, Fitting C et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NODI - and NOD2-activating agonists. Eur J Immunol 2005; 35:2459-70.
41. Takahashi Y Isuzugawa K, Murase Y et al. Up-regulation of NODI and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages. J Vet Med Sci 2006; 68:471-8.
42. Hsu LC, Ali SR, McGillivray S et al. A NOD2-NALP1 complex mediates caspase-1-dependent IL-lbeta secretion in response to Bacillus anthratis infection and muramyl dipeptide. Proc Natl Acad Sci USA 2008; 105:7803-8.
43. Pan Q, Mathison J, Fearns C et al. MDP-induced interleukin-lbeta processing requires Nod2 and CIAS1/NALP3. J Leukoc Biol 2007; 82:177-83.
44. Hedl M, Li J, Cho JH et al. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci USA 2007; 104:19440-5.
45. Mizushima N, Levine B, Cuervo AM et al. Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069-75.
46. Travassos LH, Carneiro LA, Ramjeet M et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 13:55-62.
47. Barreau F, Meinzer U, Chareyre F et al. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS One 2007; 2:e523.
48. Barreau F, Madre C, Meinzer U et al. Nod2 regulates the host response towards microti ora by modulating T cell function and epithelial permeability in mouse Peyer's patches. Gut 2010; 59:207-17.
49. Hiemstra IH, Bouma G, Geerts D et al. Nod2 improves barrierfunction of intestinal epithelial cells via enhancement of TLR responses. Mol Immunol 2012; 52:264-72.
50. Baumgart DC, Sandborn WJ Crohn's disease. Lancet 2012; 380:1590-605.
51. Cooney R, Baker J, Brain O et al. Stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16:90-9.
52. Tamura K, Fukuda Y, Sashio H et al. IL18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol 2002; 37:111-6.
53. Salvati VM, MacDonald TT, Bajaj-Elliott M et al. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 2002; 50:186-90.
54. Maerten P, Shen C, Colpaert S et al. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models. Clin Exp Immunol 2004; 135:310-7.
55. Lin J, Welker NC, Zhao Z et al. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity. Mod Pathol 2014; 27:602-8.
56. Laurila EM, Kallioniemi A. The diverse role of miR-31 in regulating cancer associated phenotypes. Genes Chromosomes Cancer 2013; 52:1103-13.
57. Brazowski E, Cohen S, Yaron A et al. FOXP3 expression in duodenal mucosa in pediatric patients with celiac disease. Pathobiology 2010; 77:328-34.
58. Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AMLl/Runxl. Nature 2007; 446:685-9.
59. Li L, Patsoukis N, Petkova V et al. Runxl and Runx3 are involved in the generation and function of highly suppressive IL-17-producing T regulatory cells. PLoS One 2012; 7:e45115.